Effect of chromogranin A (pancreastatin) fragment on invasion of prostate cancer cells.
O Nagakawa, K Murakami, M Ogasawara, J Murata, H Fuse, I Saiki
Index: Cancer Lett. 147 , 207-213, (1999)
Full Text: HTML
Abstract
We investigated the effect of chromogranin A (pancreastatin) fragment on the invasion of PC-3, DU-145 and LNCaP prostate cancer cells through a reconstituted basement membrane (Matrigel) using a Transwell cell culture chamber assay. Chromogranin A fragment increased the invasive capacity of both PC-3 and DU- 145 cells, whereas it had no significant effect of LNCaP cells. Chromogranin A fragment also increased the haptotactic migration of both PC-3 and DU-145 cells to fibronectin. Furthermore chromogranin A fragment increased the fibrinolytic activities of urokinase-type plasminogen activator (u-PA) in fibrin zymograms of both PC-3 and DU-145 cells and the expression of u-PA mRNA of PC-3 cells. However, the growth of these tumor cells was not affected by chromogranin A fragment at any concentrations used in this study. These results indicate that chromogranin A fragment increased the invasive potential of both PC-3 and DU-145 cells probably through enhancement of cell motility and the production of u-PA.
Related Compounds
Related Articles:
The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties.
2007-11-01
[Cell. Mol. Life Sci. 64 , 2863-2886, (2007)]
Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin.
2010-04-09
[Regul. Pept. 161 , 8-14, (2010)]
2003-09-01
[Urology 62 , 553-558, (2003)]